Overview
Shih-feng Cho practices in Kaohsiung, Taiwan. Cho is rated as an Advanced expert by MediFind in the treatment of Multiple Myeloma. Their top areas of expertise are Multiple Myeloma, Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, and B-Cell Lymphoma.
Their clinical research consists of co-authoring 67 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 17 articles in the study of Multiple Myeloma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- B-Cell LymphomaCho isAdvanced. Learn about B-Cell Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Multiple MyelomaCho isAdvanced. Learn about Multiple Myeloma.
- Non-Hodgkin Lymphoma
- Experienced
- Acute Myeloid Leukemia (AML)
- Adult Soft Tissue SarcomaCho isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Chronic Myelogenous Leukemia (CML)
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Hemolytic Transfusion Reaction
- HepatitisCho isExperienced. Learn about Hepatitis.